BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the launch of its new BioVerse platform.
Activist investor Elliott buys $1B+ stake in BioMarin as CEO change nears
The activist investing giant Elliott Investment Management has bought over a $1 billion stake in BioMarin, a person familiar with the matter tells Endpoints News.